TP53 and Miyoshi myopathy: In fact, several reports explored miRNAs and chemical resistance in MM drug resistant experimental models and recent papers evidenced that the p53-related signaling pathways are regulated by miRNAs, thus proposing a potential role of miRNAs in the drug response of MM cells.